Oh, William K <br/><br/>
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 2004 
 - 3705-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2004.10.195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Androgens--pharmacology<br/>Anticoagulants--administration & dosage<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Antineoplastic Agents, Phytogenic--chemistry<br/>Complementary Therapies--standards<br/>Cross-Over Studies<br/>Diethylstilbestrol--pharmacology<br/>Disease Progression<br/>Drug Contamination<br/>Drugs, Chinese Herbal--chemistry<br/>Estradiol Congeners--analysis<br/>Ethinyl Estradiol--analysis<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Prostatic Neoplasms--drug therapy<br/>Reproducibility of Results<br/>Treatment Outcome<br/>Warfarin--administration & dosage